Source:http://linkedlifedata.com/resource/pubmed/id/12878165
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2003-7-24
|
pubmed:abstractText |
Activity of the independently regulated human c-myc P0 promoter has been associated with the undifferentiated status of leukemia cells as well as the hormone-independent proliferation of breast cancer cells. The P0 transcript is distinguished from the predominant P1 and P2 c-myc mRNAs by an approximately 639-nucleotide extension of the 5'-untranslated region. We hypothesized that this complex 5'-untranslated RNA sequence unique to the P0 transcript may contribute significantly to the composite regulation of the c-myc locus and that enforced intracellular synthesis of the isolated P0 5'-UTR, out of its native sequence context, might amplify or dominantly interfere with its normal regulatory function. Human tumor (HeLa) cells in which the isolated P0 5'-UTR was ectopically expressed displayed a dramatic decrease in anchorage-independent proliferation. Furthermore, P0 5'-UTR-expressing HeLa cells failed to form tumors when inoculated into SCID mice. This loss of tumorigenicity was associated with increases in levels of the c-Myc1 (p67) and c-Myc2 (p64) proteins and a 3- to 5-fold elevation of spontaneous apoptotic index. These results demonstrate that an isolated 5'-untranslated RNA sequence can be attributed potent in trans gene-regulatory and phenotype-altering capabilities and that extrinsic alterations in c-myc regulation can be utilized to reestablish the natural proapoptotic (tumor suppressor) activities associated with this protooncogene.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0014-4827
|
pubmed:author |
pubmed-author:BlumeScott WSW,
pubmed-author:EmanuelPeter DPD,
pubmed-author:GartlandG LarryGL,
pubmed-author:GrizzleWilliam EWE,
pubmed-author:GuarcelloVincenzoV,
pubmed-author:JonesDavid EDEJr,
pubmed-author:MengZhengZ,
pubmed-author:MillerDonald MDM,
pubmed-author:RuppertJ MichaelJM,
pubmed-author:ShresthaKedarK,
pubmed-author:SnyderRichard CRC,
pubmed-author:StockardCecil RCR
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
288
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
131-42
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:12878165-5' Untranslated Regions,
pubmed-meshheading:12878165-Animals,
pubmed-meshheading:12878165-Apoptosis,
pubmed-meshheading:12878165-Base Sequence,
pubmed-meshheading:12878165-Cell Division,
pubmed-meshheading:12878165-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:12878165-HeLa Cells,
pubmed-meshheading:12878165-Humans,
pubmed-meshheading:12878165-Mice,
pubmed-meshheading:12878165-Mice, SCID,
pubmed-meshheading:12878165-Neoplasm Transplantation,
pubmed-meshheading:12878165-Proto-Oncogene Proteins c-myc,
pubmed-meshheading:12878165-RNA, Messenger,
pubmed-meshheading:12878165-Transfection
|
pubmed:year |
2003
|
pubmed:articleTitle |
Inhibition of tumorigenicity by the 5'-untranslated RNA of the human c-myc P0 transcript.
|
pubmed:affiliation |
Department of Medicine, University of Alabama at Birmingham, Tumor Institute, Room 508, 1824 6th Avenue South, Birmingham, AL 35294-3300, USA. scott.blume@ccc.uab.edu
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Research Support, Non-U.S. Gov't
|